An Antagonist of KSR1‐Driven Adaptive Resistance to Clinical RAS‐MAPK Inhibitors
Arthur Chow(Tisch Hospital), Arvin C. Dar(Memorial Sloan Kettering Cancer Center), Kyna Reyes(Icahn School of Medicine at Mount Sinai), Jayasudhan R. Yerabolu(Icahn School of Medicine at Mount Sinai), Alex Scopton(Tisch Hospital)
Cited by 0
Related Papers
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
|Annual Review of Biochemistry|2011|389
Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition
|Cell|2005|367
Formin Leaky Cap Allows Elongation in the Presence of Tight Capping Proteins
|Current Biology|2003|265